Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 84466-85-3 | MDL No. : | MFCD18642280 |
Formula : | C11H22N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VCVPSRADUBPOKJ-NSHDSACASA-N |
M.W : | 182.31 | Pubchem ID : | 11126915 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 64.38 |
TPSA : | 6.48 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.21 cm/s |
Log Po/w (iLOGP) : | 2.84 |
Log Po/w (XLOGP3) : | 1.7 |
Log Po/w (WLOGP) : | 0.8 |
Log Po/w (MLOGP) : | 1.81 |
Log Po/w (SILICOS-IT) : | 1.75 |
Consensus Log Po/w : | 1.78 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.91 |
Solubility : | 2.25 mg/ml ; 0.0123 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.45 |
Solubility : | 6.45 mg/ml ; 0.0354 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.61 |
Solubility : | 4.46 mg/ml ; 0.0245 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.04 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 215918-57-3 ]
(S)-1-(Pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 1220027-38-2 ]
1-(Pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 128454-03-5 ]
2-(Pyrrolidin-1-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 1220027-54-2 ]
2-Ethyl-1-(pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 1220027-14-4 ]
2-Methyl-1-(pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 215918-57-3 ]
(S)-1-(Pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 1220027-38-2 ]
1-(Pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 128454-03-5 ]
2-(Pyrrolidin-1-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 1220027-54-2 ]
2-Ethyl-1-(pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96
[ 1220027-14-4 ]
2-Methyl-1-(pyrrolidin-2-ylmethyl)piperidine dihydrochloride
Similarity: 0.96